The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

SARS-CoV-2 is the virus responsible for the ongoing COVID-19 outbreak. The virus uses
ACE2 receptor for viral entry. ACE2 is part of the counter-regulatory renin-angiotensin …

Objectives To investigate outcomes of Coronavirus Disease-2019 (COVID-19) in patients
with rheumatoid arthritis (RA) as compared to the general population. Additionally, outcomes …

Background Rheumatoid arthritis has been associated with severe COVID-19, but few
studies have investigated how phenotypes of rheumatoid arthritis affect these associations …

The ongoing pandemic of the novel coronavirus of 2019 (COVID-19) has resulted in over 1
million deaths, primarily affecting older patients with chronic ailments. Multiple sclerosis …

Objective To investigate coronavirus disease 2019 (COVID-19) hospitalization risk in
patients with immune-mediated inflammatory diseases (IMIDs) compared with matched non …

Objective To date, the only study that has assessed the severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2 mRNA) vaccine in systemic lupus erythematosus (SLE) …

Background Patients with celiac disease (CeD) are at increased risk of certain viral
infections and of pneumococcal pneumonia, raising concerns that they may be susceptible …

Background and aim There is increasing interest regarding SARS-CoV-2 infection in
patients with autoimmune and immune-mediated inflammatory diseases (AI/IMID) with some …

Artificial Intelligence (AI) in healthcare marks a new era of innovation and efficiency,
characterized by the emergence of sophisticated language models such as ChatGPT …